Compound Q&A
What is the market or research trend for Odanacatib (CAS: 603139-19-1)?
Answer
The market trend for Odanacatib (CAS: 603139-19-1) is positive, driven by its potential in the treatment of osteoporosis. Research is focusing on better understanding its pharmacodynamics, improving its bioavailability, and exploring its use in combination therapies. Additionally, there is growing interest in its use for bone turnover markers in clinical diagnostics.
About
CAS No
603139-19-1
English Name
Odanacatib
Molecular Formula
C25H27F4N3O3S
Molecular Weight
17.03 g/mol
SMILES
CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F
InChIKey
QGZKDVFQNNGYKY-UHFFFAOYSA-N
Last Updated: 2025-09-17 14:48
